NovaBridge Biosciences (NBP) Convertible Debt (2018 - 2020)

NovaBridge Biosciences (NBP) has 3 years of Convertible Debt data on file, last reported at $9.5 million in Q3 2020.

• Convertible Debt for Q3 2020 came in at $9.5 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2020 was $9.5 million (changed N/A YoY), and the FY2019 annual result was $9.8 million, up 1.05% from the prior year.
• Convertible Debt eased to $9.5 million in Q3 2020 per NBP's latest filing, from $9.8 million in the prior quarter.
• Over five years, Convertible Debt peaked at $9.8 million in Q2 2020 and troughed at $9.5 million in Q3 2020.
• A 3-year average of $9.7 million and a median of $9.7 million in 2018 frame the typical range for Convertible Debt.
• On a YoY basis, Convertible Debt climbed as much as 0.18% in 2019 and fell as far as 0.18% in 2019.
• A 3-year view of Convertible Debt shows it stood at $9.7 million in 2018, then decreased by 0.18% to $9.7 million in 2019, then slipped by 1.41% to $9.5 million in 2020.
• Business Quant data shows NBP's Convertible Debt at $9.5 million in Q3 2020, $9.8 million in Q2 2020, and $9.7 million in Q4 2019.